Global Veterinary Active Pharmaceutical Ingredients (API) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Veterinary Active Pharmaceutical Ingredients (API) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
Veterinary Active Pharmaceutical Ingredients (API) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Active Pharmaceutical Ingredients (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from CDMO and CMO are the major drivers for the industry.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2024 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by yearpet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 146%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Active Pharmaceutical Ingredients (API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Segment by Type
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
CDMO
CMO
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Active Pharmaceutical Ingredients (API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Active Pharmaceutical Ingredients (API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Active Pharmaceutical Ingredients (API) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Active Pharmaceutical Ingredients (API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Active Pharmaceutical Ingredients (API) introduction, etc. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Active Pharmaceutical Ingredients (API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Veterinary Active Pharmaceutical Ingredients (API) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Active Pharmaceutical Ingredients (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from CDMO and CMO are the major drivers for the industry.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2024 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by yearpet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 146%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Active Pharmaceutical Ingredients (API) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Segment by Type
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Segment by Application
CDMO
CMO
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Active Pharmaceutical Ingredients (API) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Active Pharmaceutical Ingredients (API), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Active Pharmaceutical Ingredients (API) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Active Pharmaceutical Ingredients (API) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Active Pharmaceutical Ingredients (API) introduction, etc. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Active Pharmaceutical Ingredients (API) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
